详细内容
R&D Systems位于美国的明尼苏达州,一直致力于生物制品的开发与生产。公司成立之初主要生产用于医院及临床应用的血控品。1977年,公司推出个产品--富血小板血浆质控品;1981年,公司成为全球第二家生产含血小板全血控品的供应商。40多年的发展中,R&D Systems仍持续开发各种血控品产品。
1985年,作为公司推出的个科研试剂产品,也是全球家将该产品进行商业化生产的产品,R&D Systems成功上市了TGF-beta1蛋白。作为胞外信号分子,TGF-beta1蛋白在多种细胞中进行表达,并作为胞外信号分子参与免疫功能,细胞增殖和细胞分化等生物学过程。该产品推出后,公司陆续从生物材料中纯化了几种细胞因子产品并推向市场。
天然蛋白类产品的成功推广,加速了R&D Systems在细胞因子市场的开拓。公司于1985年形成Growth Factor事业部(现Biotechnology事业部)。Biotechnology事业部的目标是生产和营销重组人细胞因子。与天然来源提取蛋白相比较,DNA重组技术生产的蛋白产品其成本更低,产量更高,完全摆脱原料的限制。1989年,Biotechnology事业部开始开发抗细胞因子的单克隆和多克隆抗体,并于1990年开发了个ELISA试剂盒。
2014年2月1009日,R&D Systems的母公司宣布命名为Bio-Techne. Bio-Techne旗下包括R&D Systems, Novus Biologicals, BiosPacific, Tocris Bioscience, Boston Biochem和Bionostics。
本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!
PLS1219 Human Integrin aV/CD51+ Endothelial/Progenitors PlusCellect (1 KT)
PLS1226 Mouse Sca-1+ Stem Cells PlusCellect (1 KT)
PLS1430 Human CD45+ Hemaoietic Cells PlusCellect (1 KT)
PLS1435 Human SSEA-4+ Pluripotent Stem Cells PlusCellect (1 KT)
PLS1658 Human Podocalyxin+ Stem Cells PlusCellect (1 KT)
PLS170 Human CXCR4+ Cancer/Stem Cells PlusCellect (1 KT)
PLS180 Human CCR5+ Cells PlusCellect (1 KT)
PLS1838 Human E-Cadherin+ Cancer/Stem Cells PlusCellect (1 KT)
PLS2155 Human/Mouse SSEA-1+ Stem Cells PlusCellect (1 KT)
PLS2408 Human NCAM-1/CD56+ NK Cells PlusCellect (1 KT)
PLS2659 Human Nectin-4+ Cancer Cells PlusCellect (1 KT)
PLS313 Human Tie-2+ Endothelial Progenitors PlusCellect (1 KT)
PLS357 Human VEGF R2+ Endothelial/Progenitor Cells PlusCellect (1 KT)
PLS358 Human HGF R/c-MET+ Cancer Cells PlusCellect (1 KT)
PLS379 Human CD4+ T Cells PlusCellect (1 KT)
PLS3870 Human Neuropilin-1+ Cells PlusCellect (1 KT)
PLS4948 Human CD44+ Cancer Stem Cells PlusCellect (1 KT)
PLS7227 Human CD34+ Hemaoietic Progenitor Cells PlusCellect (1 KT)
PLS724 Human E-Selectin/CD62E+ Endothelial Cells PlusCellect (1 KT)
PLS748 Mouse E-Cadherin+ Cancer/Stem Cells PlusCellect (1 KT)
PLS806 Human CD31/PECAM-1+ Endothelial/Progenitor Cells PlusCellect (1 KT)
PLS809 Human VCAM-1/CD106+ Endothelial Cells PlusCellect (1 KT)
PLS929 Human ACE/CD143+ Cancer/Endothelial Cells PlusCellect (1 KT)
PLS932 Human MCAM/CD146+ Cancer/Endothelial Cells PlusCellect (1 KT)
PLS938 Human VE-Cadherin+ Endothelial/Progenitor Cells PlusCellect (1 KT)
PLS960 Human EpCAM+ Cancer Cells PlusCellect (1 KT)
PP-A3409A-00 Human PPAR gamma/NR1C3 MAb (Clone A3409A) (100 UG)
PP-A8620A-00 Human G9a/EHMT2 MAb (Clone A8620A) (100 UG)
PP-A8740A-00 Human Rev-erb A alpha/NR1D1 MAb (Clone A8740A) (100 UG)
PP-A9033A-00 Human FXR/NR1H4 MAb (Clone A9033A) (100 UG)
PP-A9621A-00 Human Progesterone R/NR3C3 MAb (Clone A9621A) (100 UG)
PP-B0422-00 Mouse GLP/EHMT1 MAb (Clone B0422) (100 UG)
PP-H0037-00 Human TR2/NR2C1 MAb (Clone H0037) (100 UG)
PP-H0107B-00 Human TR4/NR2C2 MAb (Clone H0107B) (100 UG)
PP-H0502-00 Human PXR-2/NR1I2 MAb (Clone H0502) (100 UG)
PP-H0723-00 Human PPAR alpha/NR1C1 MAb (Clone H0723) (100 UG)
PP-H1415-00 Human HNF-4 alpha/NR2A1 MAb (Clone H1415) (100 UG)
PP-H1648-00 Human NGFI-B alpha/Nur77/NR4A1 MAb (Clone H1648) (100 UG)
PP-H1920-00 Human RAR alpha/NR1B1 MAb (Clone H1920) (100 UG)
PP-H2325-00 Human LRH-1/NR5A2 MAb (Clone H2325) (100 UG)
PP-H2325-10 Human LRH-1/NR5A2 MAb (Clone H2325) (100 UG)
PP-H2729-00 Human Rev-erb beta/NR1D2 MAb (Clone H2729) (100 UG)
PP-H2804-00 Human TR alpha/NR1A1 MAb (Clone H2804) (100 UG)
PP-H3122-00 Human MR/NR3C2 MAb (Clone H3122) (100 UG)
PP-H3825A-00 Human TR beta 1/NR1A2 MAb (Clone H3825A) (100 UG)
PP-H3910-00 Human ROR alpha/NR1F1 MAb (Clone H3910) (100 UG)
PP-H3925-00 Human ROR Pan Specific MAb (Clone H3925) (100 UG)
PP-H4338-00 Human RAR beta/NR1B2 MAb (Clone H4338) (100 UG)
PP-H4417-00 Human PXR Common/NR1I2 MAb (Clone H4417) (100 UG)
PP-H4537-00 Human VDR/NR1I1 MAb (Clone H4537) (100 UG)
原创作者:上海远慕生物科技有限公司
标签:
Human/Mouse SSEA-1+ Stem Cells PlusCellect
快速询价